Atherosclerosis and transit of HDL through the lymphatic vasculature

Catherine Martel1, Gwendalyn J Randolph

  • 1Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. cmartel@path.wustl.edu

Insights

Cholesterol removal from macrophages is key to halting atherosclerosis. Lymphatic vessels are crucial for clearing cholesterol from tissues, and impaired lymphatic function may drive plaque progression.

Area of Science:

  • Cardiovascular Biology
  • Atherosclerosis Research
  • Lymphatic Physiology

Background:

  • Macrophages and cholesterol are central to atherosclerotic plaque development.
  • Cholesterol efflux from macrophage foam cells is understood to inhibit disease progression.
  • High-density lipoprotein (HDL) plays a role in transporting cholesterol away from plaques.

Purpose of the Study:

  • To highlight the critical role of lymphatic vasculature in cholesterol removal from tissues.
  • To explore the connection between lymphatic function and atherosclerosis progression.
  • To discuss how impaired cholesterol removal by lymphatics may contribute to arterial plaque buildup.

Main Methods:

  • Review of recent evidence on lymphatic cholesterol transport.
  • Analysis of the relationship between tissue cholesterol efflux and lymphatic function.
  • Discussion of potential mechanisms linking lymphatic impairment to atherosclerosis.

Main Results:

  • Recent evidence implicates lymphatic vasculature in removing cholesterol from tissues, including the artery wall.
  • Cholesterol is likely transported via HDL within the lymphatic system.
  • Sluggish lymphatic removal of cholesterol may be a factor in atherosclerosis progression.

Conclusions:

  • The lymphatic system is essential for clearing cholesterol from the artery wall.
  • Dysfunctional lymphatic vasculature could contribute to the development and progression of atherosclerosis.
  • Targeting lymphatic cholesterol removal may offer new therapeutic strategies for cardiovascular disease.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lymphatic Vessels and Lymph Transport01:16

Lymphatic Vessels and Lymph Transport

Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular spaces.
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...